Go Deep
Tsubota Laboratory Incorporated
Tsubota Laboratory Incorporated Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,066 | -9.2 | 8.72 | 0.09 | 150.13 |
Tsubota Laboratory Incorporated Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 215,409,000.0 | 54,415,000.0 | 42,819,000.0 | 77,935,000.0 |
| Net Profit | -134,154,000.0 | -241,763,000.0 | -186,241,000.0 | -131,474,000.0 |
| EPS | -5.2 | — | — | — |
Tsubota Laboratory Incorporated Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 200,022,000.0 | 1,357,133,000.0 | 673,532,000.0 | 954,693,000.0 | — |
| Net Profit | -761,815,000.0 | 205,766,000.0 | -641,317,000.0 | 90,181,000.0 | — |
| EPS | -29.6 | 8.0 | -5.2 | 3.7 | — |
Tsubota Laboratory Incorporated Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,318,780,000.0 | 2,503,123,000.0 | 2,295,159,000.0 | 2,672,961,000.0 | — |
| Total Liabilities | 454,923,000.0 | 915,850,000.0 | 927,927,000.0 | 722,588,000.0 | — |
| Total Equity | 863,857,000.0 | 1,587,273,000.0 | 1,367,232,000.0 | 1,950,373,000.0 | — |
Owes vs Owns
Tsubota Laboratory Incorporated owed ¥0.44 for every ¥1 it owned in Jun 2026, up from ¥0.27 in Mar 2023.
| Period | Jun 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.44× | 0.34× | 0.37× | 0.40× | 0.27× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Tsubota Laboratory Incorporated Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 73.5%Receivables 1.1%Inventory 14.3%Fixed assets (tangible) 2.1%Other assets 8.6%
How it's funded — Mar 2026
Short-term debt 1.7%Long-term debt 3.6%Payables 0.7%Other liabilities 28.6%Shareholders' equity 65.5%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 969.8 | 1,538.9 | 1,883.4 | 2,161.0 |
| Receivables | 14.5 | 546.0 | 17.9 | 17.8 |
| Inventory | 188.9 | 285.5 | 285.5 | 355.1 |
| Fixed assets (tangible) | 27.2 | 44.0 | 52.7 | 77.9 |
| Intangible assets | 5.0 | 6.8 | 8.8 | 11.5 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 113.4 | 82.0 | 46.8 | 49.6 |
| Liabilities & equity | ||||
| Short-term debt | 22.3 | 21.2 | 26.5 | 24.5 |
| Long-term debt | 46.9 | 69.2 | 90.4 | 114.9 |
| Payables | 9.1 | 135.7 | 20.4 | 32.6 |
| Other liabilities | 376.6 | 689.8 | 790.7 | 550.6 |
| Shareholders' equity | 863.9 | 1,587.3 | 1,367.2 | 1,950.4 |
| Net tangible assets | 858.9 | 1,580.4 | 1,358.4 | 1,938.8 |
Tsubota Laboratory Incorporated Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -577,828,000.0 | -317,754,000.0 | -301,350,000.0 | 28,491,000.0 | — |
| Investing Activities | -8,409,000.0 | -14,547,000.0 | -12,001,000.0 | -54,027,000.0 | — |
| Financing Activities | 17,234,000.0 | -12,246,000.0 | 35,736,000.0 | 1,011,623,000.0 | — |